Sort
261,768 grants matching “gene therapy”
AIBP therapy
$930,000Yury Miller · University Of California, San Diego · R35 · FY2017 · HL
AIBP therapy
$930,000Yury Miller · University Of California, San Diego · R35 · FY2023 · HL
AIBP therapy
$930,000Yury Miller · University Of California, San Diego · R35 · FY2019 · HL
AIBP therapy
$930,000Yury Miller · University Of California, San Diego · R35 · FY2022 · HL
CNS sirtuins in radiation-induced vascular permeability and neurodegeneration
$929,976Deedee Smart · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV
$929,754Pamela J Skinner · University Of Minnesota · R01 · FY2022 · MH
Proteomic signatures to identify pathways underlying the progression to heart failure
$929,711Amil M Shah · Brigham And Women'S Hospital · R01 · FY2020 · HL
Altered reverse transcriptase-dependent gene diversification mechanisms in Alzheimer's disease brains
$929,705Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AG
Altered reverse transcriptase-dependent gene diversification mechanisms in Alzheimer's disease brains
$929,705Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AG
Altered reverse transcriptase-dependent gene diversification mechanisms in Alzheimer's disease brains
$929,705Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG
Altered reverse transcriptase-dependent gene diversification mechanisms in Alzheimer's disease brains
$929,705Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · AG
Altered reverse transcriptase-dependent gene diversification mechanisms in Alzheimer's disease brains
$929,705Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · AG
Functional genomic analysis of neural crest development
$929,665William J Pavan · National Human Genome Research Institute · ZIA · FY2018 · HG
Analysis of Dominant Megacolon: Another Hirschsprung Disease Model
$929,665William J Pavan · National Human Genome Research Institute · ZIA · FY2018 · HG
Discovery of solubilizing side chains for in vivo release of diverse drug classes using the Click Activated Protodrugs (CAP) platform
$929,651Nathan Yee · Tambo, Inc. · R44 · FY2024 · TR
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$929,563William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$929,509Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Necrotic survivors and plasma membrane integrity signaling
$929,204Yi-Nan Gong · University Of Pittsburgh At Pittsburgh · DP2 · FY2024 · GM
Non-human Primate (NHP Core)
$929,192James L Riley · University Of Pennsylvania · P01 · FY2025 · AI
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
$929,071Howard S. Fox · University Of Nebraska Medical Center · U01 · FY2025 · DA
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
$929,069Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2018 · CA
Epidemiology of the four most frequent cancers following breast cancer
$928,970Kathleen E Malone · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
A small molecule integrin activator to enhance cord blood transplant
$928,941Peter Vanderslice · 7 Hills Pharma, Llc · R42 · FY2021 · HL
Project 4: Cross-species Dissection of Cellular Response to APOE Genotype and AD Pathology Using Single-cell Multi-omics
$928,904Michael Ryan Corces · J. David Gladstone Institutes · P01 · FY2025 · AG
Mechanisms of non-classical multidrug resistance in cancer
$928,891Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA